Concurrent chemoradiotherapy for T3–4 and N0–1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia

Concurrent chemoradiotherapy for T3–4 and N0–1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia

The aim of this study was to evaluate the toxicity and efficacy of radiotherapy concurrent with weekly cisplatin for T3–4 and N0–1 nasopharyngeal cancer. Between 2005 and 2010, 70 patients with nasopharyngeal cancer (T3–4 N0–1 M0, World Health Organization Type 2–3) from Vietnam, Indonesia, Malaysia...

Full description

Bibliographic Details
Main Authors: Ohno, Tatsuya, Wakatsuki, Masaru, Thinh, Dang Huy Quoc, Tung, Ngo Thanh, Erawati, Dyah, Supriana, Nana, Beena Devi, C.R., Kato, Shingo, Thephamongkhol, Kullathorn, Chansilpa, Yaowalak, Calaguas, Miriam Joy C., Xiaoting, Xu, Jianping, Cao, Banu, Parvin Akhter, Cho, Chul-Koo, Karasawa, Kumiko, Nakano, Takashi, Tsujii, Hirohiko
Format: Online
Language:English
Published: Oxford University Press 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708910/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708910/

Similar Items